Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: Dose-response studies
- 28 February 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 17 (2) , 297-303
- https://doi.org/10.1016/s0735-1097(10)80090-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.Circulation, 1989
- Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmiasJournal of Clinical Epidemiology, 1987
- A Paired Prentice-Wilcoxon Test for Censored Paired DataPublished by JSTOR ,1987
- Dose-response range of encainide for benign and potentially lethal ventricular arrhythmiasThe American Journal of Cardiology, 1986
- Extracardiac adverse effects of flecainideThe American Journal of Cardiology, 1984
- Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardiaThe American Journal of Cardiology, 1983
- A Simple Method for Constructing Orthogonal Polynomials When the Independent Variable is Unequally SpacedBiometrics, 1959